Avner Yayon

13.3k citations
126 papers · 11.0k indexed · 3 hit papers · h-index 50
Topics
Fibroblast Growth Factor Research (64 papers)Proteoglycans and glycosaminoglycans research (48 papers)Osteoarthritis Treatment and Mechanisms (20 papers)

In The Last Decade

Avner Yayon

126 papers receiving 10.8k citations

Hit Papers

Cell surface, heparin-like molecules are required for bin...199120262002201419912000199250010001.5k2.0k

Peers

Avner Yayon
Comparison fields: 5 of 145
  • Molecular Biology 7.7k
  • Cell Biology 4.1k
  • Genetics 2.1k
  • Oncology 1.1k
  • Surgery 967
Replace David Moscatelli with:
David Moscatelli United States
Jeffrey S. Rubin United States
Wilson H. Burgess United States
Claudio Basilico United States
Irit Lax United States
Avri Ben‐Ze'ev Israel
Shin-Ichi Nishikawa Japan
Takako Sasaki Germany
Takeshi Imamura Japan
Minetaro Ogawa Japan
Avner Yayon relative to David Moscatelli United States David Moscatelli's profile →
Citations per field
00.5×5.4×
David Moscatelli · 1×
Citations per year

Countries citing papers authored by Avner Yayon

Since Specialization
Citations

This map shows the geographic impact of Avner Yayon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Avner Yayon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Avner Yayon more than expected).

Fields of papers citing papers by Avner Yayon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Avner Yayon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Avner Yayon. The network helps show where Avner Yayon may publish in the future.

Co-authorship network of co-authors of Avner Yayon

This figure shows the co-authorship network connecting the top 25 collaborators of Avner Yayon. A scholar is included among the top collaborators of Avner Yayon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Avner Yayon. Avner Yayon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 11
2 45
3 83
4 43
5 9
6 3
7 49
8 7
9 1
10 4
11 26
12 10
13 202
14 114
15 99
16 27
17 451
18 130
19
Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptorbreakdown →
2120
20
Flg-2, a new member of the family of fibroblast growth factor receptors.
49

About Avner Yayon

Avner Yayon is a scholar working on Cell Biology, Rheumatology and Urology, having authored 126 papers that have together received 11.0k indexed citations. Recurring topics across this work include Fibroblast Growth Factor Research (64 papers), Proteoglycans and glycosaminoglycans research (48 papers) and Osteoarthritis Treatment and Mechanisms (20 papers). The work is most often cited by research in Cell Biology (4.1k citations), Immunology and Allergy (789 citations) and Molecular Biology (7.7k citations). Avner Yayon has collaborated with scholars based in Israel, United States and Switzerland. Frequent co-authors include Philip Leder, David M. Ornitz, Michael Klagsbrun, David Givol, Jeffrey D. Esko, David Aviezer, H. Ginsburg, Peter Lonai, Z. Ioav Cabantchik and Dalit Hecht. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026